Brief: Elicera Therapeutics Resolves On Directed Issue Of Over 1.5 Mln Shares
March 20 (Reuters) - Elicera Therapeutics AB ELIC.ST: RESOLVES ON DIRECTED ISSUE OF 1,533,512 SHARES SUBSCRIPTION PRICE IN COMPENSATION ISSUE SET AT SEK 1.85 Source text: ID:nWkr52lDVg Further company coverage: ELIC.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Elicera Therapeutics AB
See all newsBrief: Elicera Therapeutics Completes Phase I Part Of Carma Study
Brief: Elicera Therapeutics Gets Medical Products Agency Approval To Advance CARMA Study
Brief: Elicera Gets Clearance To Use Highest ELC-301 Dose Ahead Of Phase IIa
Brief: Elicera Gets First Patent Allowance For ELC-201
Brief: Elicera Receives Notice Of Allowance For U.S. Patent Application